ERD-1233
ERD-1233 is a potent, orally bioavailable PROTAC that selectively degrades the estrogen receptor with a DC50 of 0.9 nM. It is a valuable chemical tool for investigating ERα biology and is used in both in vitro and in vivo studies of ER-positive breast cancer.
Product Specifications
Field of Research
Metabolism Research, Pharmacology & Drug Discovery
Molecular Formula
C49H53N5O6
Molecular Weight
807.98
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog